Covidien denies layoffs tied to device tax

Covidien logo

Although Covidien (NYSE:COV) chairman, president & CEO Jose Almeida considers the impending 2.3% medical device tax "absurd," he’s far from implementing dramatic gestures to cope with the new burden.

The company confirmed with that reports of layoffs and overseas shifts ahead of the levy were inaccurate, despite being widely disseminated.

"While we believe the medical device tax may hurt investment in innovation and research & development, Covidien has never cited the device tax as a reason for laying off employees or transferring production to other locations," a company spokeswoman told us.

Indeed, Covidien has bucked the norm in its rhetoric on the medical device, calling the levy "just another business issue" that the company will handle.

In a recent call with investors, Almeida declined to comment on how the device titan would deal with the tax, but said that the company would explore its options in much the manner it would for any other issue that comes its way.

"For Covidien internally, we need to deal with this like we deal with any business issue," Almeida said. "It’s a business issue for us so there’s cost reductions that we’re attempting to put through to be able to offset. But all options are open and we’re evaluating every single one of them."

A recent op-ed, penned by famed conservative columnist George Will and published in the Washington Post yesterday, blamed the device tax for 200 layoffs and the company’s decision to shift some of its production overseas. The article appeared in a number of outlets including the Boston Herald, Kansas City Star and the San Diego Union Tribune.

George Will did not reply to requests for comment.

Some medical device makers have publicly announced job cuts directly tied to the tax. Stryker (NYSE:SYK) announced last November that it would lay off 5% of its workforce in order to offset the impact of the tax. Zimmer (NYSE:ZMH) cited the tax as part of the motivation for cutting up to 180 jobs before the end of this year.

Yet Covidien has remained resolutely demure in the face of the tax, which could endanger more than 43,000 jobs by one estimate.

"We’re looking at a number of different options right now," Covidien CFO Charles Dockendorff told investors in a conference call in January. "But again, our commitment has been to long-term, double-digit EPS growth over time. And we don’t think that something like that, particularly, should knock us off that goal. We get these kind of increases in raw materials or currency that are far greater than that all the time. So it’s just another business issue, that we will deal with as we look in 2013."

News of Covidien’s alleged tax-driven layoffs seems to tie back to a comment made by conservative pundit Ramesh Ponnuru in an opinion piece for Bloomberg, in which he dubbed the med-tech levy the "tongue depressor tax."

"Covidien Plc, maker of surgical instruments, said it would lay off 200 workers in the U.S. and move production to Costa Rica and Mexico. It, too, cited the tax," Ponnuru wrote.

He cited an article reporting Covidien’s July 2011 decision to close a med-tech manufacturing facility in Argyle, New York, and a separate article about the company’s expansion plans overseas, neither of which appeared to point the finger at the med-tech tax as the motivating factor.

The link between Covidien’s layoffs and the device tax later appeared in reports by the National Center for Policy Analysis, the Senate Republicans Conference, Becker’s ASC Review and, most recently, George Will’s widely reproduced column.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply